JP Morgan Call 290 TGT 16.01.2026/ DE000JK86GA1 /
2024-05-31 11:05:10 AM | Chg.+0.010 | Bid10:00:39 PM | Ask10:00:39 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.140EUR | +7.69% | - Bid Size: - |
- Ask Size: - |
Target Corp | 290.00 USD | 2026-01-16 | Call |
GlobeNewswire
11:05 PM
Eldorado Gold Publishes 2023 Sustainability Report; Our Sustainability Framework in Action
GlobeNewswire
11:02 PM
Charge Enterprises, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy L...
GlobeNewswire
10:56 PM
Enphase Energy, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law F...
GlobeNewswire
10:42 PM
Prospect Floating Rate and Alternative Income Fund Announces an Increased 7.5% Annualized Total Cash...
GlobeNewswire
10:33 PM
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s...
GlobeNewswire
10:30 PM
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
GlobeNewswire
10:15 PM
Earlyworks and ZenmuTech collaborate for a more secure digital society through secret splitting and ...
GlobeNewswire
10:10 PM
Consolidated Water Announces Partial Adjournment of Annual General Meeting and Information for Recon...
GlobeNewswire
10:07 PM
Triumph Financial Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferr...
GlobeNewswire
10:05 PM
TEN, Ltd. Announces Date of First Quarter 2024 Results, Conference Call and Webcast
GlobeNewswire
10:05 PM
Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc....
GlobeNewswire
10:05 PM
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...
GlobeNewswire
10:01 PM
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)